Connect with us

Hi, what are you looking for?

Smart Success StrategySmart Success Strategy

Editor's Pick

Appendix 4D and Half Yearly Accounts

Cleo Diagnostics (COV:AU) has announced Appendix 4D and Half Yearly Accounts Download the PDF here. This post appeared first on investingnews.com

6 hours ago

Editor's Pick

Argo Launches Digital Gold Investment Platform in the US, Aims to Disrupt Industry

Argo Digital US has launched its 24/7 gold investment platform in the US. In an early February announcement, the Sprott family-backed company said the...

8 hours ago

Editor's Pick

Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced that it has completed its trial entitled “A...

10 hours ago

Editor's Pick

Waiver of ASX Listing Rule 10.1 Granted

Hydration solutions company The Hydration Pharmaceuticals Company Limited (ASX: HPC) (Hydralyte North America or the Company) refers to its announcement dated 27 March 2024...

April 26, 2024

Editor's Pick

Rio Silver (TSXV:RIO)

Overview Rio Silver (TSXV:RYO) is a precious metals mining and exploration company with a focus on the acquisition, exploration and development of precious metals...

April 26, 2024

Editor's Pick

Falco Resources

Overview Falco Resources (TSXV:FPC) is a Canadian company focused on developing gold and base metal projects in the Rouyn-Noranda region of Quebec. Rouyn-Noranda is...

April 26, 2024

Editor's Pick

Top 3 Canadian Pharma Stocks of 2024

From established players to up-and-coming firms, Canada’s pharmaceutical landscape is diverse and dynamic. Three months into 2024, market watchers are keeping a close eye...

April 25, 2024
More Posts
Enter Your Information Below To Receive Latest News, And Articles.



    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Disclaimer: smartsuccessstrategy.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartsuccessstrategy.com